These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 19818400
1. Phenotypic changes in ciprofloxacin-resistant Staphylococcus aureus. Mesak LR, Davies J. Res Microbiol; 2009 Dec; 160(10):785-91. PubMed ID: 19818400 [Abstract] [Full Text] [Related]
3. Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002. Noguchi N, Okihara T, Namiki Y, Kumaki Y, Yamanaka Y, Koyama M, Wakasugi K, Sasatsu M. Int J Antimicrob Agents; 2005 May; 25(5):374-9. PubMed ID: 15848290 [Abstract] [Full Text] [Related]
6. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus. Nagel M, Reuter T, Jansen A, Szekat C, Bierbaum G. Int J Med Microbiol; 2011 Mar; 301(3):229-36. PubMed ID: 21115395 [Abstract] [Full Text] [Related]
7. The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae. Sierra JM, Cabeza JG, Ruiz Chaler M, Montero T, Hernandez J, Mensa J, Llagostera M, Vila J. Clin Microbiol Infect; 2005 Sep; 11(9):750-8. PubMed ID: 16104991 [Abstract] [Full Text] [Related]
10. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. Sabatini S, Kaatz GW, Rossolini GM, Brandini D, Fravolini A. J Med Chem; 2008 Jul 24; 51(14):4321-30. PubMed ID: 18578473 [Abstract] [Full Text] [Related]
11. Opposing effects of aminocoumarins and fluoroquinolones on the SOS response and adaptability in Staphylococcus aureus. Schröder W, Goerke C, Wolz C. J Antimicrob Chemother; 2013 Mar 24; 68(3):529-38. PubMed ID: 23169893 [Abstract] [Full Text] [Related]
13. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin. Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H. J Antimicrob Chemother; 2009 May 24; 63(5):886-94. PubMed ID: 19279051 [Abstract] [Full Text] [Related]
14. Ciprofloxacin and trimethoprim cause phage induction and virulence modulation in Staphylococcus aureus. Goerke C, Köller J, Wolz C. Antimicrob Agents Chemother; 2006 Jan 24; 50(1):171-7. PubMed ID: 16377683 [Abstract] [Full Text] [Related]
17. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli. Zhao X, Quinn B, Kerns R, Drlica K. J Antimicrob Chemother; 2006 Dec 17; 58(6):1283-6. PubMed ID: 17003060 [Abstract] [Full Text] [Related]
18. PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa. Blázquez J, Gómez-Gómez JM, Oliver A, Juan C, Kapur V, Martín S. Mol Microbiol; 2006 Oct 17; 62(1):84-99. PubMed ID: 16956383 [Abstract] [Full Text] [Related]
19. Associations between resistance phenotype and gene expression in response to serial exposure to oxacillin and ciprofloxacin in Staphylococcus aureus. Uddin MJ, Ahn J. Lett Appl Microbiol; 2017 Dec 17; 65(6):462-468. PubMed ID: 28977678 [Abstract] [Full Text] [Related]